Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04494256 |
|---|---|
| Brief Title: | A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation (ALSpire) |
| First Submitted : | July 30, 2020 |
| First Submitted that Met QC Criteria : | July 30, 2020 |
| First Posted : | July 31, 2020 |
| Last Update Submitted that Met QC Criteria : | October 3, 2023 |
| Last Update Posted : | October 5, 2023 |